Alembic Q1 FY27 Results: Revenue Rs 48 Cr, PAT Rs 15 Cr and Key Highlights

Alembic Q1 FY27 results were announced on August 11, 2026, reporting a net profit (PAT) of Rs 15 crore, down 11.85% from Rs 17 crore in Q1 FY26. Revenue from operations contracted 2.03% year on year to Rs 48 crore from Rs 49 crore in Q1 FY26. The Alembic Q1 FY27 results are on a consolidated basis for the quarter ended June 30, 2026.

Click Here – Get Free Investment Predictions

Alembic Q1 FY27 Financial Highlights

The table below summarises the key financial metrics from the Alembic Q1 FY27 results compared with the same quarter of the previous year (Q1 FY26).

Metric	Q1 FY27 (Jun 2026)	Q1 FY26 (Jun 2025)	YoY Change
Revenue from Operations (Rs Cr)	Rs 48 Cr	Rs 49 Cr	-2.03%
Gross Profit (Rs Cr)	Rs 11 Cr	Rs 16 Cr	-28.75%
Net Profit / (Loss) – PAT (Rs Cr)	Rs 15 Cr	Rs 17 Cr	-11.85%

Alembic Q1 FY27 Performance Analysis

Use the Univest Screener to Track Live Fundamentals of Indian Stocks

Alembic q1 fy27 results show a revenue decline of 2.03% year on year to Rs 48 crore. Gross profit declined to Rs 11 crore from Rs 16 crore in Q1 FY26.

Net profit in the June 2026 quarter stood at Rs 15 crore, a 11.85% decrease year on year. Investors tracking Alembic quarterly results should verify these figures against the official BSE and NSE filings.

Key Business Factors in Alembic Q1 FY27

1. Revenue Trend Sets the Quarterly Context

Revenue contracted 2.03% year on year to Rs 48 crore, reflecting near-term headwinds in the Pharmaceuticals segment.

2. Gross Profit and Margin Movement

Gross profit fell to Rs 11 crore from Rs 16 crore in Q1 FY26. Higher input costs or pricing pressure weighed on gross margins.

3. Net Profit Outcome in the June Quarter

PAT came in at Rs 15 crore, down 11.85% from Rs 17 crore in Q1 FY26. Consistent profitability will depend on revenue momentum and margin trends through FY27.

Dividend Details

No dividend has been declared alongside the Alembic quarterly results for the quarter ended June 2026. Investors may track future announcements via BSE India and NSE India portals.

Alembic FY27 Outlook After Q1 Results

The June 2026 quarterly performance of Alembic presents a mixed picture heading into the rest of FY27. Gross margin improvement will be critical for the company to strengthen its financial position. Investors tracking Alembic Q1 results should monitor management guidance, sector demand in Pharmaceuticals, and any strategic moves that could alter the earnings trajectory.

Alembic Stock Performance

Download the Univest iOS App or Univest Android App to track Alembic live share price and upcoming quarterly results.

Alembic share price stood at Rs 86.87 on August 11, 2026, the day the quarterly results were declared. Post-results, the market will assess whether the Pharmaceuticals company's financial performance justifies the current valuation. Investors should verify the latest price and fundamentals on BSE and NSE before making any investment decision.

Key Risks to Watch After Alembic Q1 FY27 Results

1. Sector-Specific Demand Headwinds

A slowdown in the Pharmaceuticals sector could weigh on Alembic revenue and profitability beyond what the June 2026 quarter already reflects.

2. Input Cost and Margin Pressure

Rising raw material or operational costs could compress gross margins and limit net profit recovery in subsequent quarters of FY27.

3. Macroeconomic and Regulatory Uncertainty

Inflation, interest rate movements, and regulatory changes remain key risks to the earnings trajectory of Alembic through FY27.

Conclusion

Alembic Q1 FY27 results report revenue of Rs 48 crore and a net profit (PAT) of Rs 15 crore, down 11.85% from Rs 17 crore in Q1 FY26. The June 2026 quarterly performance reflects the company's position in the Pharmaceuticals space. Investors should study the full financials on BSE and NSE and consult a SEBI-registered advisor before making any investment decision.

Frequently Asked Questions on Alembic Q1 FY27 Results

When were the Alembic Q1 FY27 results announced?

Ans. The June 2026 quarterly results for Alembic were announced on August 11, 2026, covering the quarter ended June 30, 2026. The consolidated results were filed with BSE and NSE on the same date.

What is the PAT in the Alembic Q1 FY27 results?

Ans. PAT (net profit) stood at Rs 15 crore in the June 2026 quarter, down 11.85% from Rs 17 crore in Q1 FY26.

What was the revenue in the Alembic Q1 FY27 results?

Ans. Revenue for the June 2026 quarter fell 2.03% year on year to Rs 48 crore from Rs 49 crore in Q1 FY26.

Did Alembic announce any dividend with the Q1 FY27 results?

Ans. No dividend has been declared alongside the June 2026 quarterly results. Investors may track future Alembic dividend announcements through the BSE and NSE portals.

What is the Alembic FY27 outlook after Q1 results?

Ans. The June 2026 quarterly performance signals a challenging start to FY27 for Alembic. Key factors to watch include revenue trends, margin performance, and Pharmaceuticals sector demand through the rest of the financial year.

Is Alembic a good buy after Q1 FY27 results?

Ans. The Q1 FY27 financial performance of Alembic reflects challenging trends in the June 2026 quarter. This article is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered investment advisor.